nct_id: NCT04650880
age: Adults
cancer_center_accrual_goal_upper: 0
data_table4: Interventional
drug_list:
  drug:
  - drug_name: 'Other: Placebo'
  - drug_name: 'Dietary Supplement: Vitamin D'
long_title: A Randomized Double-blind Controlled Trial on the Effect of Vitamin D
  on Ovulation Rate of Women With Polycystic Ovary Syndrome
management_group_list:
  management_group:
  - is_primary: Y
    management_group_name: Group1
oncology_group_list:
  oncology_group:
  - group_name: Group1
    is_primary: N
phase: NA
principal_investigator: ''
principal_investigator_institution: The University of Hong Kong
program_area_list:
  program_area:
  - is_primary: Y
    program_area_name: Program1
protocol_id: 0
protocol_no: ''
protocol_target_accrual: 220
protocol_type: INTERVENTIONAL
prior_treatment_requirements:
- 'Inclusion Criteria:'
- '* Premenopausal'
- '* Aged 18-40 years'
- '* Irregular long menstrual cycles (\>35 days)'
- '* PCOS according to the Rotterdam criteria'
- '* Agree for transvaginal ultrasound'
- 'Exclude - Exclusion Criteria:'
- Exclude - * Use of hormonal medication (including contraception) within 3 months
  prior to study inclusion, except the use of a progestogen to induce withdrawal bleeding
  every 3 months
- Exclude - * History of any medical condition or medications that may predispose
  to vitamin D sensitivity, altered vitamin D metabolism and/ or hypercalcemia, including
  active tuberculosis or current therapy for tuberculosis, sarcoidosis, history of
  renal/ ureteral stones, parathyroid disease, renal or liver failure or current use
  of anti-convulsants
- Exclude - * Use of insulin-sensitizing drugs, lipid lowering drugs or anti-hypertensive
- Exclude - * Anticipated to use the above medications in the coming one year
- Exclude - * Known type 2 diabetes mellitus
- Exclude - * Refusal to join the study
- Exclude - * Abnormal blood calcium level
- Exclude - For those on supplements, we asked them to stop their own supplements.
short_title: Effect of Vitamin D on Ovulation Rate in Women With Polycystic Ovary
  Syndrome
site_list:
  site: []
sponsor_list:
  sponsor:
  - is_principal_sponsor: Y
    sponsor_name: The University of Hong Kong
    sponsor_protocol_no: ''
    sponsor_roles: sponsor
staff_list:
  protocol_staff: []
status: open to accrual
summary: This is a randomized double-blind controlled trial on the effect of vitamin
  D supplementation to assess the ovulation rate of women with polycystic ovary syndrome
  (PCOS) and other reproductive, endocrine and metabolic outcomes after one year of
  treatment.
treatment_list:
  step:
  - arm:
    - arm_code: Vitamin D
      arm_internal_id: 0
      arm_description: Vitamin D 50,000 IU/ week for 4 weeks, followed by 50,000 IU
        once every 2 weeks for 52 weeks Those who remain anovulatory after 6 months
        will be treated with a 6-month course of letrozole (2.5mg to 7.5mg for 5 days
        per cycle titrated according to response) for ovulation induction.
      arm_suspended: N
      dose_level:
      - level_code: '0'
        level_description: 'Dietary Supplement: Vitamin D'
        level_internal_id: 0
        level_suspended: N
    - arm_code: Placebo
      arm_internal_id: 1
      arm_description: Placebo tablets with same external appearance for 52 weeks
        Those who remain anovulatory after 6 months will be treated with a 6-month
        course of letrozole (2.5mg to 7.5mg for 5 days per cycle titrated according
        to response) for ovulation induction.
      arm_suspended: N
      dose_level:
      - level_code: '0'
        level_description: 'Other: Placebo'
        level_internal_id: 0
        level_suspended: N
    match:
    - and:
      - clinical:
          oncotree_primary_diagnosis: ''
          disease_status:
          - ''
          - ''
      - genomic:
          hugo_symbol: ''
          variant_category: ''
